Lineage Cell Therapeutics
LCTX
$1.08
Share price
-4.89%
Change (1 day)
-17.94%
Change (1 year)
Categories
Lineage Cell Therapeutics (LCTX) - Total assets
Total assets on the balance sheet as of December 2023 : $0.10 B
According to Lineage Cell Therapeutics 's latest financial reports the company's total assets are $0.10 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Lineage Cell Therapeutics - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.10 B | -18.31% |
| 2022-12-31 | $0.12 B | -29.15% |
| 2021-12-31 | $0.17 B | 61.69% |
| 2020-12-31 | $0.10 B | -13.97% |
| 2019-12-31 | $0.12 B | 23.43% |
| 2018-12-31 | $0.10 B | -41.32% |
| 2017-12-31 | $0.17 B | 21.51% |
| 2016-12-31 | $0.14 B | 50.61% |
| 2015-12-31 | $94.66 M | 26.38% |
| 2014-12-31 | $74.9 M | 29.74% |
| 2013-12-31 | $57.72 M | 94.06% |
| 2012-12-31 | $29.74 M | -35.09% |
| 2011-12-31 | $45.82 M | -13.97% |
| 2010-12-31 | $53.27 M | 296.58% |
| 2009-12-31 | $13.43 M | 1197.31% |
| 2008-12-31 | $1.03 M | 491.35% |
| 2007-12-31 | $0.17 M | -73.08% |
| 2006-12-31 | $0.65 M | -66.79% |
| 2005-12-31 | $1.95 M | 28.73% |
| 2004-12-31 | $1.52 M | 42% |
| 2003-12-31 | $1.07 M | -28.38% |
| 2002-12-31 | $1.49 M | -22.94% |
| 2001-12-31 | $1.94 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.25 B | 149.46% | 🇺🇸 USA |